达唑氧苯 T7968

Product Introduction
Bioactivity


英文名: Dazoxiben

描述: Dazoxiben (UK-37248) 是口服具有活性的血栓烷合酶抑制剂。

体外活性: Dazoxiben, an orally active TX-synthase inhibitor, on platelet and renal TXB2 production and associated changes in PG-endoperoxide metabolism. Dazoxiben inhibits TXB2 production in clotting human whole blood with an IC50 of 0.3 micrograms/ml and causes parallel enhancement of PGE2 greater than PGF2 alpha greater than 6-keto-PGF1 alpha production[1].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 62.5 mg/mL (232.60 mM)


关键字: Dazoxiben | UK37248 | Inhibitor | UK 37248 | inhibit

相关产品: BGC201531 | NXT-10796 | Afzelin | Carboprost | α-Viniferin | ONO-8713 | sphondin | 4-O-Cinnamoylquinic acid | L-902688 | Murrangatin

相关库: Anti-Aging Compound Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Human Metabolite Library | Inhibitor Library | GPCR Compound Library | Endocrinology-Hormone Compound Library | Orally Active Compound Library | NO PAINS Compound Library | Bioactive Compound Library

达唑氧苯 T7968信息由TargetMol中国为您提供，如您想了解更多关于达唑氧苯 T7968报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途